Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression.
Papandreou CN, Usmani B, Geng Y, Bogenrieder T, Freeman R, Wilk S, Finstad CL, Reuter VE, Powell CT, Scheinberg D, Magill C, Scher HI, Albino AP, Nanus DM.
Papandreou CN, et al. Among authors: nanus dm.
Nat Med. 1998 Jan;4(1):50-7. doi: 10.1038/nm0198-050.
Nat Med. 1998.
PMID: 9427606